Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

Gregory Y. H. Lip; Nikolaos Dagres; Alessandro Proclemer; Jesper Hastrup Svendsen; Laurent Pison; Carina Blomstrom-Lundqvist

doi:10.1093/europace/eus413

Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

Gregory Y. H. Lip^*, Nikolaos Dagres, Alessandro Proclemer, Jesper Hastrup Svendsen, Laurent Pison, Carina Blomstrom-Lundqvist

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73) centres performed 10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being othe patient has absolute contraindication to long term oral anticoagulants'. Among survey respondents, LAAO procedures are most often performed by interventional cardiologists. Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, bleeding) complications reported by the respondents to this EP wire survey.

Original language	English
Pages (from-to)	141-143
Journal	EP Europace
Volume	15
Issue number	1
DOIs	https://doi.org/10.1093/europace/eus413
Publication status	Published - Jan 2013

Keywords

Anticoagulation
Atrial fibrillation
Left atrial appendage occlusion
Stroke

Access to Document

10.1093/europace/eus413

Cite this

@article{78dcfa17774847419eb485786a02d407,

title = "Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey",

abstract = "The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73) centres performed 10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being othe patient has absolute contraindication to long term oral anticoagulants'. Among survey respondents, LAAO procedures are most often performed by interventional cardiologists. Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, bleeding) complications reported by the respondents to this EP wire survey.",

keywords = "Anticoagulation, Atrial fibrillation, Left atrial appendage occlusion, Stroke",

author = "Lip, {Gregory Y. H.} and Nikolaos Dagres and Alessandro Proclemer and Svendsen, {Jesper Hastrup} and Laurent Pison and Carina Blomstrom-Lundqvist",

year = "2013",

month = jan,

doi = "10.1093/europace/eus413",

language = "English",

volume = "15",

pages = "141--143",

journal = "EP Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

AU - Lip, Gregory Y. H.

AU - Dagres, Nikolaos

AU - Proclemer, Alessandro

AU - Svendsen, Jesper Hastrup

AU - Pison, Laurent

AU - Blomstrom-Lundqvist, Carina

PY - 2013/1

Y1 - 2013/1

N2 - The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73) centres performed 10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being othe patient has absolute contraindication to long term oral anticoagulants'. Among survey respondents, LAAO procedures are most often performed by interventional cardiologists. Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, bleeding) complications reported by the respondents to this EP wire survey.

AB - The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73) centres performed 10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being othe patient has absolute contraindication to long term oral anticoagulants'. Among survey respondents, LAAO procedures are most often performed by interventional cardiologists. Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, bleeding) complications reported by the respondents to this EP wire survey.

KW - Anticoagulation

KW - Atrial fibrillation

KW - Left atrial appendage occlusion

KW - Stroke

U2 - 10.1093/europace/eus413

DO - 10.1093/europace/eus413

M3 - Article

SN - 1099-5129

VL - 15

SP - 141

EP - 143

JO - EP Europace

JF - EP Europace

IS - 1

ER -